Status:

RECRUITING

Meningococcal B Vaccine in Patients with Asplenia

Lead Sponsor:

Medical University of Vienna

Conditions:

Splenectomy; Status

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

Brief Summary

Patients without a spleen (asplenia) experience an increased risk for septicaemia from encapsulated bacteria, which is associated with a high mortality rate. Meningococcal bacteria can cause such infe...

Detailed Description

This study is a prospective open-label phase II pilot study to assess the immunogenicity and safety of BEXSERO® in asplenic patients. Patients participating in the study will complete a total of four ...

Eligibility Criteria

Inclusion

  • For asplenic patients:
  • asplenia due to splenectomy or functional asplenia
  • 18 to 60 years of age
  • if female: have a negative urine pregnancy test result at study entry and agree to employ adequate birth control measures for the duration of the study
  • providing written informed consent
  • For healthy controls:
  • 18 to 60 years of age
  • if female: have a negative urine pregnancy test result at study entry and agree to employ adequate birth control measures for the duration of the study
  • providing written informed consent

Exclusion

  • For asplenic patients:
  • pregnant or lactating
  • febrile illness within last two weeks prior to enrolment
  • allergic reactions to vaccination in past
  • chemotherapy with Rituximab within last six months or during study period
  • more than 20mg prednisone per day within last four weeks prior or at the time of enrolment
  • previous vaccination against meningococcal serogroup B
  • For healthy controls:
  • pregnant or lactating
  • febrile illness within last two weeks prior to enrolment
  • allergic reactions to vaccination in past
  • any immunosuppressive condition or medication
  • previous vaccination against meningococcal serogroup B

Key Trial Info

Start Date :

March 12 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2025

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06025487

Start Date

March 12 2024

End Date

December 31 2025

Last Update

November 22 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical University Vienna

Vienna, Vienna, Austria, 1090